CC BY-NC-ND 4.0 · Asian J Neurosurg 2024; 19(04): 707-714
DOI: 10.1055/s-0044-1789247
Original Article

Prediction of Postoperative Recurrence of Chronic Subdural Hematoma Using Preoperative Systemic Immune Inflammation Index and Eosinophils

1   Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Anurag Sahu
1   Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Ravi Shankar Prasad
1   Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Debabrata Deb
1   Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Devendra Kumar
1   Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Abjad Karimi
1   Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
› Author Affiliations
Funding None.

Abstract

Objective Chronic subdural hematoma (CSDH) is a common neurological problem with significant recurrence after surgery. Risk considerations can vary, ranging from patient-related factors to those related to the surgical procedure. This study explores the association between preoperative eosinophil count and systemic immune inflammation (SII) with CSDH recurrence.

Materials and Methods We conducted a prospective analysis of 105 patients with equal numbers of CSDHs who underwent surgery for CSDH between January 2023 and January 2024. The preoperative eosinophil counts, along with other differential leukocyte counts, were measured. The SII index was calculated using the standard formula (SII = neutrophil count  ×  platelet count/lymphocyte count). Multivariate and univariate regression analyses were performed to assess the association between risk factors and CSDH recurrence.

Results The preoperative eosinophil count showed a significant correlation with recurrence (p < 0.001). The SII index was significantly higher in patients with recurrent CSDH (p = 0.003). Neutrophils were found to be significantly associated with CSDH recurrence (p = 0.038). Age (p < 0.001) and SII (p = 0.005) were found to be independent predictors of CSDH recurrence, whereas hematoma volume (p < 0.001) and the antiplatelet regimen were a significant predictor of CSDH recurrence (p = 0.047). Variables like male gender, diabetes mellitus, anticoagulants, and hematoma volume were associated with eosinophil-rich or eosinophil-poor status.

Conclusion Preoperative eosinophil count, neutrophils, and the SII index may serve as potential predictors of CSDH recurrence. Further studies with larger sample sizes are needed to validate these findings.

Supplementary Material



Publication History

Article published online:
21 August 2024

© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Tamura R, Sato M, Yoshida K, Toda M. History and current progress of chronic subdural hematoma. J Neurol Sci 2021; 429: 118066
  • 2 Nouri A, Gondar R, Schaller K, Meling T. Chronic subdural hematoma (cSDH): a review of the current state of the art. Brain Spine 2021; 1: 100300
  • 3 Gillett G. Subdural hematoma. Camb Q Healthc Ethics 2017; 26 (04) 527-529
  • 4 Aladawi M, Elfil M, Najdawi ZR. et al. Aneurysmal Subdural Hematoma: A Systematic Review. Neurocrit Care 2024; 41 (01) 244-254
  • 5 Chen H, Colasurdo M, Malhotra A, Gandhi D, Bodanapally UK. Advances in chronic subdural hematoma and membrane imaging. Front Neurol 2024; 15: 1366238
  • 6 Foppen M, Bandral HV, Slot KM, Vandertop WP, Verbaan D. Success of conservative therapy for chronic subdural hematoma patients: a systematic review. Front Neurol 2023; 14: 1249332
  • 7 Maroufi SF, Farahbakhsh F, Macdonald RL, Khoshnevisan A. Risk factors for recurrence of chronic subdural hematoma after surgical evacuation: a systematic review and meta-analysis. Neurosurg Rev 2023; 46 (01) 270
  • 8 Liu LX, Cao XD, Ren YM, Zhou LX, Yang CH. Risk factors for recurrence of chronic subdural hematoma: a single center experience. World Neurosurg 2019; 132: e506-e513
  • 9 Cofano F, Pesce A, Vercelli G. et al. Risk of recurrence of chronic subdural hematomas after surgery: a multicenter observational cohort study. Front Neurol 2020; 11: 560269
  • 10 Zhang Y, Yang Y, Long S, Li G. Assessment of peripheral blood cell inflammatory markers in patients with chronic subdural hematoma. Clin Neurol Neurosurg 2020; 191: 105738
  • 11 de Oliveira AJM, Solla DJF, de Oliveira KF. et al. Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence. Neurol Sci 2022; 43 (01) 427-434
  • 12 Davidson B, Narvacan K, Munoz DG. et al. The crucial role of eosinophils in the life cycle, radiographical architecture, and risk of recurrence of chronic subdural hematomas. Neurotrauma Rep 2021; 2 (01) 76-83
  • 13 Lin MS. Subdural lesions linking additional intracranial spaces and chronic subdural hematomas: a narrative review with mutual correlation and possible mechanisms behind high recurrence. Diagnostics (Basel) 2023; 13 (02) 235
  • 14 Gigon L, Fettrelet T, Yousefi S, Simon D, Simon HU. Eosinophils from A to Z. Allergy 2023; 78 (07) 1810-1846
  • 15 Kanda A, Yun Y, Bui DV. et al. The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions. Allergol Int 2021; 70 (01) 9-18
  • 16 Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14 (01) 108
  • 17 Holl DC, Volovici V, Dirven CMF. et al; Dutch Chronic Subdural Hematoma Research Group (DSHR). Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to present to future. World Neurosurg 2018; 116: 402-411.e2
  • 18 Fan Y, Wu D, Zhang X. et al. The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients. J Clin Lab Anal 2022; 36 (10) e24706
  • 19 Tota M, Łacwik J, Laska J, Sędek Ł, Gomułka K. The role of eosinophil-derived neurotoxin and vascular endothelial growth factor in the pathogenesis of eosinophilic asthma. Cells 2023; 12 (09) 1326
  • 20 Matsubara M, Yagi K, Minami Y. et al. Preoperative elevated eosinophils in peripheral blood for prediction of postoperative recurrence of chronic subdural hematoma. J Neurosurg 2023; 139 (03) 708-713
  • 21 Stanisic M, Aasen AO, Pripp AH. et al. Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res 2012; 61 (08) 845-852
  • 22 Huang YW, Yin XS, Li ZP. Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: a systematic review and meta-analysis. Front Immunol 2022; 13: 1090305
  • 23 Lotocki G, de Rivero Vaccari JP, Perez ER. et al. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma 2009; 26 (07) 1123-1134
  • 24 Han J, Yang L, Lou Z, Zhu Y. Association between systemic immune-inflammation index and systemic inflammation response index and outcomes of acute ischemic stroke: a systematic review and meta-analysis. Ann Indian Acad Neurol 2023; 26 (05) 655-662
  • 25 Adachi A, Higuchi Y, Fujikawa A. et al. Risk factors in chronic subdural hematoma: comparison of irrigation with artificial cerebrospinal fluid and normal saline in a cohort analysis. PLoS One 2014; 9 (08) e103703
  • 26 Ramirez GA, Yacoub MR, Ripa M. et al. Eosinophils from physiology to disease: a comprehensive review. BioMed Res Int 2018; 2018: 9095275
  • 27 Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res 2011; 343 (01) 57-83
  • 28 Valent P, Klion AD, Horny HP. et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130 (03) 607-612.e9
  • 29 Killeffer JA, Killeffer FA, Schochet SS. The outer neomembrane of chronic subdural hematoma. Neurosurg Clin N Am 2000; 11 (03) 407-412
  • 30 Moskala M, Goscinski I, Kaluza J. et al. Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies. Microsc Microanal 2007; 13 (03) 211-219
  • 31 Li F, Hua C, Feng Y, Yuan H, Bie L. Correlation of vascular endothelial growth factor with magnetic resonance imaging in chronic subdural hematomas. J Neurol Sci 2017; 377: 149-154
  • 32 Uhl B, Vadlau Y, Zuchtriegel G. et al. Aged neutrophils contribute to the first line of defense in the acute inflammatory response. Blood 2016; 128 (19) 2327-2337
  • 33 Long A, Kleiner A, Looney RJ. Immune dysregulation. J Allergy Clin Immunol 2023; 151 (01) 70-80
  • 34 Zhu B, Yu X, Ou Y, Guo X, Liu W, Wu L. Nutritional and inflammatory peripheral blood markers for risk assessment of chronic subdural hematoma: a case-control study. Clin Neurol Neurosurg 2023; 227: 107640
  • 35 Kayalar AE, Ozlu EBK, Etli MU, Calisaneller AT. Evaluation of peripheral blood inflammatory markers in patients with chronic subdural hematoma. Neurol India 2024; 72 (02) 340-344
  • 36 Li S, Liu K, Gao Y. et al. Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis. Stroke Vasc Neurol 2020; 5 (04) 368-373
  • 37 Chen L, Pandey S, Shen R, Xu Y, Zhang Q. Increased systemic immune-inflammation index is associated with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage patients. Front Neurol 2021; 12: 745175
  • 38 Xu H, Wu W, Zhu Q. et al. Systemic immune-inflammation index predicts the prognosis of traumatic brain injury. World Neurosurg 2024; 183: e22-e27
  • 39 Chen L, Xia S, Zuo Y. et al. Systemic immune inflammation index and peripheral blood carbon dioxide concentration at admission predict poor prognosis in patients with severe traumatic brain injury. Front Immunol 2023; 13: 1034916
  • 40 Honda M, Maeda H. Intraoperative hematoma volume can predict chronic subdural hematoma recurrence. Surg Neurol Int 2021; 12: 232
  • 41 Hirai S, Yagi K, Hara K, Kanda E, Matsubara S, Uno M. Postoperative recurrence of chronic subdural hematoma is more frequent in patients with blood type A. J Neurosurg 2021; 135 (04) 1203-1207
  • 42 Zhu F, Wang H, Li W. et al. Factors correlated with the postoperative recurrence of chronic subdural hematoma: an umbrella study of systematic reviews and meta-analyses. EClinicalMedicine 2021; 43: 101234
  • 43 Georgountzos G, Gkalonakis I, Anastasopoulos L, Stranjalis G, Kalamatianos T. Biofluid biomarkers in the prognosis of chronic subdural hematoma: a systematic scoping review. Diagnostics (Basel) 2023; 13 (14) 2449